Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Esperion Therapeutics, Inc.

ESPR · — · CIK 0001434868 · Healthcare

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

17 Form 4 transaction lines observed in the same window
3 sales · 14 option, withholding, award, gift or other lines

Last qualifying purchase2023-05-11 · CARROLL J MARTIN · $36.3K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesLow
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Looker BenjaminChief Legal Officer
▼○
Koenig Sheldon L.President and CEO
▼○
Halladay BenjaminChief Financial Officer
▼○
THOMPSON JOHN CRAIGDirector
○○
Shepard JayDirector
○○
Hoffman Robert E.Director
○○
● Purchase▼ Sale○ Other

Showing the six most active owners; 3 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2023-05-11 · CARROLL J MARTIN.

Recent Form 4 activity

0Purchases
10Sales
18Other Form 4 lines
28SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING3 sale line(s) · context only
OTHER14 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

The FINRA report lists no short interest for this ticker.

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2023-05-11CARROLL J MARTINPurchase (P)Common Stock23,091USD 1.57USD 36,253SEC filing ↗
2023-05-10ROCAMBOLI STEPHENPurchase (P)Common Stock8,111USD 1.50USD 12,166SEC filing ↗
2023-05-10CARROLL J MARTINPurchase (P)Common Stock8,409USD 1.49USD 12,529SEC filing ↗
2023-05-09Koenig Sheldon L.Purchase (P)Common Stock20,000USD 1.26USD 25,200SEC filing ↗
2022-08-31Warren EricPurchase (P)Common Stock1,000USD 7.46USD 7,460SEC filing ↗
2022-08-05Koenig Sheldon L.Purchase (P)Common Stock8,606USD 5.80USD 49,915SEC filing ↗
2022-06-02CARROLL J MARTINPurchase (P)Common Stock5,000USD 5.64USD 28,200SEC filing ↗
2021-05-24BB BIOTECH AG; BIOTECH TARGET N VPurchase (P)Common Stock100,000USD 20.22USD 2,022,000SEC filing ↗
2021-05-19BB BIOTECH AG; BIOTECH TARGET N VPurchase (P)Common Stock200,000USD 20.37USD 4,074,000SEC filing ↗
2021-05-06BB BIOTECH AG; BIOTECH TARGET N VPurchase (P)Common Stock80,000USD 20.57USD 1,645,600SEC filing ↗
2021-05-05BB BIOTECH AG; BIOTECH TARGET N VPurchase (P)Common Stock150,000USD 20.02USD 3,003,000SEC filing ↗
2020-11-03BB BIOTECH AG; BIOTECH TARGET N VPurchase (P)Common Stock200,000USD 25.31USD 5,062,000SEC filing ↗
2020-03-11MAYLEBEN TIMOTHY MPurchase (P)Common Stock2,500USD 43.00USD 107,500SEC filing ↗
2020-02-28MAYLEBEN TIMOTHY MPurchase (P)Common Stock5,000USD 49.00USD 245,000SEC filing ↗
2020-01-23BB BIOTECH AG; BIOTECH TARGET N VPurchase (P)Common Stock20,000USD 52.12USD 1,042,400SEC filing ↗

Form 4 evidence

28 transaction lines in the latest 365-day window; 169 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-07-13THOMPSON JOHN CRAIGD (D)Common Stock79,873USD —USD —SEC filing ↗
2026-07-13Shepard JayD (D)Common Stock164,472USD —USD —SEC filing ↗
2026-07-13Looker BenjaminD (D)Common Stock667,524USD —USD —SEC filing ↗
Show recent Form 4 evidence (28 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-07-13THOMPSON JOHN CRAIGD (D)Common Stock79,873USD —USD —SEC filing ↗
2026-07-13Shepard JayD (D)Common Stock164,472USD —USD —SEC filing ↗
2026-07-13Looker BenjaminD (D)Common Stock667,524USD —USD —SEC filing ↗
2026-07-13Koenig Sheldon L.D (D)Common Stock2,121,094USD —USD —SEC filing ↗
2026-07-13Hoffman Robert E.D (D)Common Stock85,153USD —USD —SEC filing ↗
2026-07-13Harlow John B. Jr.D (D)Common Stock424,536USD —USD —SEC filing ↗
2026-07-13Halladay BenjaminD (D)Common Stock705,410USD —USD —SEC filing ↗
2026-07-13Fischer Seth H. Z.D (D)Common Stock141,023USD —USD —SEC filing ↗
2026-07-13CARROLL J MARTIND (D)Common Stock177,523USD —USD —SEC filing ↗
2026-06-17Looker BenjaminSale (S)Common Stock11,824USD 3.16USD 37,364SEC filing ↗
2026-06-17Koenig Sheldon L.Sale (S)Common Stock53,588USD 3.16USD 169,338SEC filing ↗
2026-06-17Halladay BenjaminSale (S)Common Stock10,773USD 3.16USD 34,043SEC filing ↗
2026-05-28THOMPSON JOHN CRAIGAward / grant (A)Common Stock79,873USD 0.00USD 0SEC filing ↗
2026-05-28Shepard JayAward / grant (A)Common Stock79,873USD 0.00USD 0SEC filing ↗
2026-05-28Hoffman Robert E.Award / grant (A)Common Stock79,873USD 0.00USD 0SEC filing ↗
2026-05-28Fischer Seth H. Z.Award / grant (A)Common Stock79,873USD 0.00USD 0SEC filing ↗
2026-05-28CARROLL J MARTINAward / grant (A)Common Stock79,873USD 0.00USD 0SEC filing ↗
2026-03-17Looker BenjaminSale (S)Common Stock5,708USD 2.70USD 15,412SEC filing ↗
2026-03-17Koenig Sheldon L.Sale (S)Common Stock25,578USD 2.72USD 69,572SEC filing ↗
2026-03-17Halladay BenjaminSale (S)Common Stock6,424USD 2.71USD 17,409SEC filing ↗
2026-03-13Looker BenjaminAward / grant (A)Common Stock300,840USD 0.00USD 0SEC filing ↗
2026-03-13Koenig Sheldon L.Award / grant (A)Common Stock723,760USD 0.00USD 0SEC filing ↗
2026-03-13Halladay BenjaminAward / grant (A)Common Stock247,430USD 0.00USD 0SEC filing ↗
2026-01-20Looker BenjaminSale (S)Common Stock1,689USD 2.88USD 4,864SEC filing ↗
2025-12-17Looker BenjaminSale (S)Common Stock6,517USD 3.67USD 23,917SEC filing ↗
2025-12-17Koenig Sheldon L.Sale (S)Common Stock48,244USD 3.67USD 177,055SEC filing ↗
2025-12-17Halladay BenjaminSale (S)Common Stock7,337USD 3.67USD 26,927SEC filing ↗
2025-12-04Harlow John B. Jr.Award / grant (A)Common Stock424,536USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerESPR
CIK0001434868
SectorHealthcare
Industry— Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
Exchange—

Data coverage

Local Form 4 history169 transaction lines from 2020-01-02 to 2026-07-13
15 P purchase lines · 68 S sale lines · 86 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.